Insider buying by the BOD is a good sign. As I posted earlier the catalysts are still there and BARDA is being underestimated. Rickey David good for 32K. With cash needs solved for time being they are no longer negotiating with their backs against the wall but they better move quickly to avoid de ja vu.
Insider purchases in the open market would have far more meaning than them ponying up a few bucks at discounted rates on the backs of existing shareholders.
I would also add that this strengthens their position for a partnership flies in the face of what other respected YMB members have suggested that the science is thier strength...I lean toward your point of view only slightly because the amounts they raise are meaningless imho. If there was a deal in place and only ironing out the final language was the issue then OK....but we have heard this same story with each raise and no one has cowarded and said "where do I sign for a partnership" to date.
I have argued extensively in the past that CYTX needed 200 million and could probably get by with 150 million. This would worry the short side enough and also get them thru unexpected delays (although everything is unexpected with this management team) BARDA helps some and if taken to completion. This raise also helps. Again, I also stated/agrued that the piece meal raises would not have the same desired effect on PPS.
Where we go from here is anyones guess.
The insider buys to me indicates no deal in the very near term.
Calhoun again absent despite President and Chairman of BOD buys.
These guys bought last year.
December 2012 and we are below some of the purchase prices.
Millions of more shares floated via Seaside and Lazard.
Partnership we know was a false prophecy.
Where is CMI approval ?
Where is the first treated ADVANCE study patient ?
Increased compensation for 2011 failures. 2012 failures should be a compensation package off the charts.